MedTrace Logo

Effects of Regulatory Tools on Work Environment and Employee Health

NCT03855163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2555

Last updated 2022-05-06

No results posted yet for this study

Summary

This study evaluates the effects of the Labour Inspection Authority's regulatory tools on workplace exposures to prevent employee ill health. Norwegian municipal enterprises with employees in the home care sector have been randomized to three different experimental groups and to one control group. We hypothesize a significant lower level of work environmental exposures and health complaints, after adjusting for pre-intervention measures, in the experimental groups compared to the control group.

Conditions

  • Occupational Health
  • Sick Leave
  • Occupational Exposure

Interventions

BEHAVIORAL

Inspection visits

Normative intervention aimed at enforcing compliance with legal occupational health and safety requirements

BEHAVIORAL

Guidance workshops

Pedagogical intervention aimed to motivate managers and employee representatives to comply with legal occupational health and safety requirements

BEHAVIORAL

Online risk assessment tool

Pedagogical intervention aimed to motivate managers and employee representatives to comply with legal occupational health and safety requirements

Sponsors & Collaborators

  • Norwegian Labour Inspection Authority

    collaborator UNKNOWN

  • National Institute of Occupational Health, Norway

    lead OTHER_GOV

Principal Investigators

  • Håkon A Johannessen, PhD · National Institute of Occupational Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
67 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-05
Primary Completion
2020-11-30
Completion
2022-02-25

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03855163 on ClinicalTrials.gov